Berkeley, Inc Abbott Laboratories Transaction History

Berkeley, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Mar 04, 2025	SELL	$116.66 - $129.06 $204,621 - $226,371	-1,754 Closed	0 $0
Q2 2021 Mar 28, 2025	SELL	$105.79 - $124.53 $6,241 - $7,347	-59 Reduced 3.25%	1,754 $203 Million
Q2 2021 Mar 04, 2025	SELL	$105.79 - $124.53 $6,241 - $7,347	-59 Reduced 3.25%	1,754 $203 Million
Q1 2021 Mar 28, 2025	BUY	$108.84 - $128.23 $197,326 - $232,480	1,813 New	1,813 $217 Million
Q1 2021 Mar 04, 2025	SELL	$108.84 - $128.23 $55,943 - $65,910	-514 Reduced 22.09%	1,813 $217 Million
Q4 2020 Mar 28, 2025	BUY	$105.0 - $114.42 $244,335 - $266,255	2,327 New	2,327 $255 Million
Q4 2020 Feb 28, 2025	BUY	$105.0 - $114.42 $244,335 - $266,255	2,327 New	2,327 $255 Million

3,541

1.38B

9.75M

8.87M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $234B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Berkeley, Inc, based on Form 13F filings with the SEC.

Stay updated on Berkeley, Inc with notifications on news.